GPR17 and glioblastoma: Consistent with our analysis, Mutharasu et al. [18] reported that GPR17 interacted with about 30 different crucial pathways in glioblastoma multiforme signaling networks, and suggested that GPR17 mediated signaling networks could be used as a therapeutic target for GBM.